Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Return on Capital Employed (2017 - 2025)

Historic Return on Capital Employed for Anaptysbio (ANAB) over the last 9 years, with Q3 2025 value amounting to 0.09%.

  • Anaptysbio's Return on Capital Employed rose 2600.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 2600.0%. This contributed to the annual value of 0.27% for FY2024, which is 600.0% up from last year.
  • According to the latest figures from Q3 2025, Anaptysbio's Return on Capital Employed is 0.09%, which was up 2600.0% from 0.25% recorded in Q2 2025.
  • Anaptysbio's 5-year Return on Capital Employed high stood at 0.02% for Q3 2021, and its period low was 0.43% during Q2 2024.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.23% (2023), whereas its average is 0.22%.
  • In the last 5 years, Anaptysbio's Return on Capital Employed plummeted by -2200bps in 2022 and then soared by 2600bps in 2025.
  • Quarter analysis of 5 years shows Anaptysbio's Return on Capital Employed stood at 0.11% in 2021, then crashed by -78bps to 0.2% in 2022, then plummeted by -94bps to 0.38% in 2023, then skyrocketed by 32bps to 0.26% in 2024, then skyrocketed by 64bps to 0.09% in 2025.
  • Its Return on Capital Employed was 0.09% in Q3 2025, compared to 0.25% in Q2 2025 and 0.25% in Q1 2025.